What does CUSIP 75886F107 represent in this 13F holders report?

CUSIP 75886F107 is the security identifier for REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in Q2 2023?

1156 institutional investors reported REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)

CUSIP: 75886F107

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock
Total 13F shares: 91,953,885
Total 13F value: $66,140,528,710
Share change: -738,036
Put/Call ratio: 115%
SEC-reported price per share: $718.54
Number of holders: 1,156
Value change: -$553,052,249
Number of buys: 470
Number of sells: 573
Shares outstanding: 103,945,862

Security key

75886F107

Report period

Q2 2023

Institutions

1,156

Top holders

REGN full security history Ownership snapshot Full 13F holder table REGENERON PHARMACEUTICALS, INC. SEC filings REGENERON PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FMR LLC

Disclosed value leader

FMR LLC

Comparable rows

15/15

Latest evidence

31 Mar 2023

13F Lead comparable stake: 9.1% Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 9.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Comparable ownership Top 5

FMR LLC 9.1%

BlackRock Finance, Inc. 9.1%

VANGUARD GROUP INC 8.5%

JPMORGAN CHASE & CO 6.1%

Capital World Investors 5.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FMR LLC	13F Company 13F	9.1%	$7,756,643,117 9,440,096 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	9.1%	$7,738,734,725 9,418,300 shares	—	31 Mar 2023
VANGUARD GROUP INC	13F Company 13F	8.5%	$7,273,522,262 8,852,121 shares	—	31 Mar 2023
JPMORGAN CHASE & CO	13F Company 13F	6.1%	$5,212,800,224 6,344,151 shares	—	31 Mar 2023
Capital World Investors	13F Company 13F	5.6%	$4,790,765,482 5,830,586 shares	—	31 Mar 2023
STATE STREET CORP	13F Company 13F	4.7%	$4,020,930,869 4,893,616 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,156

91,953,885

Rows available

1,156

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

1,182

Q2 2023 holders

1,156

Holder diff

-26

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %